| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | $5.11M | $5.82M | $5.99M | $7.81M |
| Cost of Revenue | – | $1.21M | $1.63M | $2.29M | $1.60M |
| Gross Profit | – | $3.90M | $4.19M | $3.70M | $6.21M |
| Operating Expenses | $4.64M | $21.58M | $17.81M | $23.62M | $24.26M |
| R&D | – | $2.62M | $2.41M | $1.74M | $1.79M |
| SG&A | $4.64M | $8.75M | $9.26M | $12.21M | $15.59M |
| Operating Income | -$4.64M | -$17.68M | -$13.62M | -$19.92M | -$18.05M |
| Interest Expense | – | $560.91K | $536.14K | $596.02K | $368.66K |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | $0.00 |
| Net Income | $1.91M | -$14.32M | -$8.16M | -$20.04M | -$8.99M |
| EPS (basic) | -1.5600 | -3.3400 | -6.3500 | -9.6800 | -0.8300 |
| EPS (diluted) | -1.5600 | -3.3400 | -6.3500 | -9.6800 | -0.8300 |
| Shares (diluted) | $28.07M | $8.03M | $2.18M | $2.07M | $10.89M |